S. HÜLAGÜ, "Daily İFN alpha 2b ribavirin R combination for Chronic Hepatitis C CHC patients relapsing or non responding to previous İFN administration preliminary report at 12 week," Gastroenterology 116(4) G3236 , part 2 APR 1999.( Ayrıca bu çalışma American College of Gastroenterology 64th Annual Scientific Meeting October 18-20 1999 toplantısında sunulmuştur.) , 2000
HÜLAGÜ, S. 2000. Daily İFN alpha 2b ribavirin R combination for Chronic Hepatitis C CHC patients relapsing or non responding to previous İFN administration preliminary report at 12 week. Gastroenterology 116(4) G3236 , part 2 APR 1999.( Ayrıca bu çalışma American College of Gastroenterology 64th Annual Scientific Meeting October 18-20 1999 toplantısında sunulmuştur.) .
HÜLAGÜ, S., (2000). Daily İFN alpha 2b ribavirin R combination for Chronic Hepatitis C CHC patients relapsing or non responding to previous İFN administration preliminary report at 12 week . Gastroenterology 116(4) G3236 , part 2 APR 1999.( Ayrıca bu çalışma American College of Gastroenterology 64th Annual Scientific Meeting October 18-20 1999 toplantısında sunulmuştur.)
HÜLAGÜ, SADETTİN. "Daily İFN alpha 2b ribavirin R combination for Chronic Hepatitis C CHC patients relapsing or non responding to previous İFN administration preliminary report at 12 week," Gastroenterology 116(4) G3236 , part 2 APR 1999.( Ayrıca bu çalışma American College of Gastroenterology 64th Annual Scientific Meeting October 18-20 1999 toplantısında sunulmuştur.), 2000
HÜLAGÜ, SADETTİN. "Daily İFN alpha 2b ribavirin R combination for Chronic Hepatitis C CHC patients relapsing or non responding to previous İFN administration preliminary report at 12 week." Gastroenterology 116(4) G3236 , part 2 APR 1999.( Ayrıca bu çalışma American College of Gastroenterology 64th Annual Scientific Meeting October 18-20 1999 toplantısında sunulmuştur.) , 2000
HÜLAGÜ, S. (2000) . "Daily İFN alpha 2b ribavirin R combination for Chronic Hepatitis C CHC patients relapsing or non responding to previous İFN administration preliminary report at 12 week." Gastroenterology 116(4) G3236 , part 2 APR 1999.( Ayrıca bu çalışma American College of Gastroenterology 64th Annual Scientific Meeting October 18-20 1999 toplantısında sunulmuştur.) .
@conferencepaper{conferencepaper, author={SADETTİN HÜLAGÜ}, title={Daily İFN alpha 2b ribavirin R combination for Chronic Hepatitis C CHC patients relapsing or non responding to previous İFN administration preliminary report at 12 week}, congress name={Gastroenterology 116(4) G3236 , part 2 APR 1999.( Ayrıca bu çalışma American College of Gastroenterology 64th Annual Scientific Meeting October 18-20 1999 toplantısında sunulmuştur.)}, city={}, country={}, year={2000}}